OncoMed Pharmaceuticals Inc Deferred Revenue Recognized
OncoMed Pharmaceuticals Inc reported Deferred Revenue Recognized of $7.80 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2018-05-08
- OncoMed Pharmaceuticals Inc contract with customer, liability, revenue recognized for the quarter ending 2018-03-31 was $7.80M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month |
|---|---|
| 2018-03-31 | $7.80M 10-Q · filed 2018-05-08 |